As LIF inhibition holds promise in targeted HCC therapy, we aimed to discover an LIF inhibitor while evaluating its anti‐tumor effect and illuminating its mechanisms by targeting LIF. The gene discussed is LIF; the disease is hepatocellular carcinoma.